With OCPM from Celonis, AstraZeneca GBS shifted to a comprehensive, end-to-end view of its processes, enabling teams to:
- Analyze different subprocesses holistically.
- Understand upstream and downstream impacts between subprocesses.
- Visualize multiple business objects simultaneously.
- Identify and map relationships and interactions between these business objects.
The results have been both transformative and measurable:
📉 Streamlined data collection, reducing manual effort and saving valuable time. ⚙️ Enhanced workflows, driving efficiency across the supply chain. 🚀 Accelerated medicines delivery, ensuring patients receive lifesaving medicines faster. 📦 Optimised inventory levels, unlocking cost savings and reducing waste.
These improvements have delivered significant value within inventory management, marking a major milestone in AstraZeneca GBS’s journey toward operational excellence.
Looking to the future, the organization is excited to use Celonis OCPM to additional brands and processes, unlocking even greater value: “It will allow us to expand this existing use case to additional brands using OCPM. Rather than having to replicate separate case-based models for different purposes, we can now augment our existing OCPM model.”
This innovative approach not only accelerates the rollout of optimized processes but also reinforces the role of Process Mining as a driver of enterprise-wide transformation.